Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis
,
BGXs aggregate liability arising from an order will not exceed the amount paid for the product giving rise to the claim
In view of the paucity of benefits, the Panel concluded that the risk/benefit ratio was too high for routine clinical use
with more progressive features including hypotension, bradycardia, tetany, drowsiness, respiratory depression and coma
US$ 24.66
US$ 25.30
US$ 21.31
US$ 24.35
US$ 27.29
US$ 23.37
